Opendata, web and dolomites

ReHaptix

Easy-to-use and highly accurate medical software for quantitative assessment of impairments in neurologically injured people.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ReHaptix project word cloud

Explore the words cloud of the ReHaptix project. It provides you a very rough idea of what is the project "ReHaptix" about.

lack    ms    diseases    medical    mhealth       worldwide    disease    supervised    home    limited    parkinson    functional    solutions    healthcare    designed    validated    app    caused    25    population    hospital    schedule    expensive    validation    objectively    impairments    chronic    medication    private    ce    appointment    clinic    disorders    performing    neurological    accuracy    stroke    share    drastically    perform    injured    autonomously    rehabilitation    treatment    clinically    assessments    gold    tests    percentage    software    65    innovation    rehaptix    greatest    obtain    feasibility    initiated    device    remotely    hcps    aged    patients    people    multiple    evidences    trials    progress    grow    clinical    30m    plan    optimize    sclerosis    standard    quantitative    mark    touchscreen    monitor    professionals    remote    recovery    neurologically    market    tablet    setting    empowers    drafted    supply    treating    adapt    either    doctor    strategy    validity    chain   

Project "ReHaptix" data sheet

The following table provides information about the project.

Coordinator
REHAPTIX GMBH 

Organization address
address: STAUFFACHERSTRASSE 151
city: ZURICH
postcode: 8004
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://rehaptix.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REHAPTIX GMBH CH (ZURICH) coordinator 50˙000.00

Map

 Project objective

Neurological disorders, caused by either stroke, multiple sclerosis (MS) or Parkinson’s diseases affect more than 30M people worldwide. Currently, Europe has the greatest percentage of population aged 65 or over (25%) and these numbers are expected to drastically grow (3% per year) increasing the population affected by these chronic conditions. Neurological rehabilitation is an expensive doctor-supervised program designed for treating these diseases. However, there is currently no effective assessment to objectively measure and monitor the rehabilitation progress. Current solutions for performing assessments do not provide clinical evidences of their validity, show lack of accuracy and are limited to one disease type. ReHaptix has developed a medical software, designed for remote quantitative assessment of impairments in neurologically injured people. ReHaptix has developed 9 tests so far, of which 4 have been clinically validated (the gold standard), and 5 are currently under clinical validation. Healthcare Professionals (HCPs) can use the ReHaptix tests to evaluate their patients in the hospital, rehabilitation clinic or private practice, or patients can perform the tests autonomously at home on a touchscreen tablet, which empowers them about their recovery. Furthermore, patients can remotely share their results with their HCPs, who can adapt the treatment and medication, or schedule medical appointment and home-setting assessments as required. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, ReHaptix will optimize the software increasing the number of tests and developing a functional mHealth app. Clinical trials will then be initiated to obtain the CE mark as a medical device.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REHAPTIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REHAPTIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

Nocturne (2019)

The eye as a window to the brain, extending lifelong brain health

Read More  

Reuse as a service (2019)

Reusable packaging as a service for e-commerce

Read More